Förmaksflimmer - ny kunskap ger nya behandlingsmöjligheter

Translated title of the contribution: Atrial fibrillation--new knowledge yields new therapeutic possibilities

Bertil Olsson, Jonas Carlson, Tomas Fahraeus, Anders P Hansson, Eva Hertervig, Max Ingemansson, Ole Kongstad Rasmussen, Carl-Johan Lindholm, Carl Meurling, Pyotr Platonov, Anders Roijer, Shiwen Yuan

Research output: Contribution to journalArticlepeer-review


Atrial fibrillation (AF) is the most common cardiac arrhythmia prompting treatment. Advances in our knowledge of the pathophysiology of AF provide the basis for new and improved treatment modalities. Thus, focal excitation and localised impulse conduction defects are possible trigger factors which can be counteracted by focal ablation and pacing synchronisation, respectively. Perpetuation of AF, caused by continuous multisite re-entry, is promoted by successive shortening of repolarisation. Internal defibrillation and anatomical limitation of re-entry are treatments that counteract perpetuation of the arrhythmia. Current knowledge of AF and the application of new treatments are discussed by the Lund AF research group.
Translated title of the contributionAtrial fibrillation--new knowledge yields new therapeutic possibilities
Original languageSwedish
Pages (from-to)3796-3803
Issue number36
Publication statusPublished - 1999

Subject classification (UKÄ)

  • Cardiac and Cardiovascular Systems


  • Förmaksflimmer


Dive into the research topics of 'Atrial fibrillation--new knowledge yields new therapeutic possibilities'. Together they form a unique fingerprint.

Cite this